HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"L 31/48
EN
Official Journal of the European Union
5.2.2011
COMMISSION DECISION
of 4 February 2011
authorising the placing on the market of a fish (Sardinops sagax) peptide product as a novel food
ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council
(notified under document C(2011) 522)
(Only the English text is authentic)
(2011/80/EU)
THE EUROPEAN COMMISSION,
(7)
On the basis of the scientific assessment, it is established
that the fish peptide product complies with the criteria
Having regard to the Treaty on the Functioning of the European
laid down in Article 3(1) of Regulation (EC) No 258/97.
Union,
Having regard to Regulation (EC) No 258/97 of the European
(8) The
measures
provided
for
in
this
Decision
are
in
Parliament and of the Council of 27 January 1997 concerning
accordance with the opinion of the Standing
novel foods and novel food ingredients ( 1 ), and in particular
Committee on the Food Chain and Animal Health,
Article 7 thereof,
HAS ADOPTED THIS DECISION:
Whereas:
(1) On
28
April
2008
the
company
of
Senmi
Ekisu
Co.
Ltd
Article 1
made a request to the competent authorities of Finland
The fish (Sardinops sagax) peptide product as specified in Annex
to place a fish (Sardinops sagax) peptide product on the
I may be placed on the market in the Union as a novel food
market as a novel food ingredient.
ingredient for the uses listed in Annex II.
(2) On
12
January
2009
the
competent
food
assessment
body of Finland issued its initial assessment report. In
Article 2
that report it came to the conclusion that the fish
The designation of fish (Sardinops sagax) peptide product au-
peptide product may be placed on the market.
thorised by this Decision on the labelling of the foodstuff
(3) The
Commission
forwarded
the
initial
assessment
report containing it shall be ‘fish (Sardinops sagax) peptides’.
to all Member States on 10 March 2009.
Article 3
(4) Within
the
60-day
period
laid
down
in
Article
6(4)
of
Regulation (EC) No 258/97 reasoned objections to the
This Decision is addressed to Senmi Ekisu Co. Ltd, Research &
marketing of the product were raised in accordance with
Development Department, 779-2 Noda, Hirano-Cho, Ohzu-
that provision.
City, Ehime 795-0021, Japan.
(5) Therefore
the
European
Food
Safety
Authority
(EFSA)
was consulted on 14 August 2009.
Done at Brussels, 4 February 2011.
(6) On 9 July 2010, EFSA (Panel on Dietetic Products,
Nutrition and Allergies) in the ‘Scientific opinion on
the safety of “Sardine Peptide Product” as a novel food
For the Commission
ingredient’ ( 2 ) came to the conclusion that the fish
peptide product was safe under the proposed conditions
John DALLI
of use and the proposed levels of intake.
Member of the Commission
( 1 ) OJ L 43, 14.2.1997, p. 1.
( 2 ) EFSA Journal 2010; 8(7): 1684.

---

EN
5.2.2011 Official
Journal
of
the
European
Union L
31/49
ANNEX I
SPECIFICATIONS OF FISH (SARDINOPS SAGAX) PEPTIDE PRODUCT
Description
The novel food ingredient is a peptide mixture, which is obtained by an alkaline protease-catalysed hydrolysis of fish
(Sardinops sagax) muscle, subsequent isolation of the peptide fraction by column chromatography, concentration under
vacuum and spray drying. It is a yellowish white powder.
Specification of fish (Sardinops sagax) peptide product
Peptides (*)
≥ 85 g/100 g
(short chain peptides, dipeptides and tripeptides with a molecular
weight of less than 2 kDa)
Val-Tyr (dipeptide) 0,1
to
0,16
g/100
g
Ash
≤ 10 g/100 g
Moisture
≤ 8 g/100 g
(*) Kjeldahl method.
ANNEX II
USES OF THE FISH PEPTIDE PRODUCT
Use group Maximum
level
of
fish
peptide
product
Foods based on yoghurt, yoghurt drinks, fermented milk products,
0,48 g/100 g (ready to eat/drink)
and powdered milk
Flavoured water, and vegetable-based drinks 0,3
g/100
g
(ready
to
drink)
Breakfast cereals 2
g/100
g
Soups, stews and soup powders 0,3
g/100
g
(ready
to
eat)

---